Internal Medicine, Hematology & Oncology · Denton, TX
NPI
1154522209
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2900 N I-35 Ste 100
Denton, TX, 76201
Phone (940) 484-5323
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.3M
192,603 services
Medicare patients, 2024
908
Average age 75
Drug cost, 2024
$5.0M
2,525 prescriptions
Company payments, 2025
$6,359
From 45 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anant Sharma was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 17,340 times for 17 patients. In total Anant Sharma billed 192,603 services in 169 codes, and Medicare paid $2.3M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-08-18.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 17,340 | 17 | $0.28 | $4,780 |
| J1453 Injection, fosaprepitant, 1 mg | Office | 15,600 | 34 | $0.09 | $1,361 |
| J1756 Injection, iron sucrose, 1 mg | Office | 12,600 | 30 | $0.17 | $2,187 |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 12,045 | 31 | $2.30 | $28K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 10,806 | 111 | $0.10 | $1,100 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 8,100 | 14 | $44.96 | $364K |
| J9267 Injection, paclitaxel, 1 mg | Office | 4,659 | 11 | $0.08 | $376 |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 2,000 | 19 | $16.22 | $32K |
| J0897 Injection, denosumab, 1 mg | Office | 1,800 | 19 | $19.97 | $36K |
| 85025 Blood Count | Office | 1,638 | 577 | $7.59 | $12K |
| 80053 Clinical Chemistry | Office | 1,530 | 578 | $10.32 | $16K |
| 36415 Venipuncture Blood Collection | Office | 1,521 | 580 | $8.64 | $13K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,459 | 46 | $0.60 | $870 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,365 | 52 | $0.09 | $119 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 882 | 485 | $11.56 | $10K |
By year: 2022 $2.7M for 180,909 services; 2023 $2.0M for 156,461 services; 2024 $2.3M for 192,603 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,638 | 577 | $7.59 | $12K |
| 80053 Clinical Chemistry | 1,530 | 578 | $10.32 | $16K |
| 36415 Venipuncture Blood Collection | 1,521 | 580 | $8.64 | $13K |
| 82728 Clinical Chemistry | 421 | 228 | $13.36 | $5,625 |
| 83540 Clinical Chemistry | 421 | 228 | $6.34 | $2,669 |
| 83550 Clinical Chemistry | 421 | 228 | $8.57 | $3,608 |
| 83615 Clinical Chemistry | 281 | 175 | $5.88 | $1,653 |
| 85055 Blood Count | 163 | 75 | $35.03 | $5,710 |
| 83735 Clinical Chemistry | 124 | 25 | $6.47 | $803 |
| 85007 Blood Count | 105 | 43 | $3.72 | $391 |
Medicare prescription drug claims, 2024
In 2024, the drug Anant Sharma prescribed most often to Medicare patients was Letrozole, with 198 prescriptions and refills. In total Anant Sharma wrote 2,525 Medicare prescriptions that cost $5.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 198 | 461 | 59 | $4,739 |
| Eliquis Apixaban | 193 | 280 | 44 | $153K |
| Tamoxifen Citrate Generic | 102 | 248 | 32 | $2,644 |
| Hydroxyurea Generic | 88 | 177 | 21 | $1,603 |
| Allopurinol Generic | 85 | 195 | 26 | $833 |
| Xarelto Rivaroxaban | 84 | 146 | 20 | $78K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 76 | 76 | 32 | $1,684 |
| Revlimid Lenalidomide | 70 | 70 | Under 11 | $1.1M |
| Acyclovir Generic | 67 | 150 | 20 | $883 |
| Ondansetron Odt Ondansetron | 66 | 66 | 42 | $1,135 |
| Prednisone Generic | 59 | 83 | 21 | $382 |
| Dexamethasone Generic | 57 | 83 | 21 | $991 |
| Alendronate Sodium Generic | 55 | 149 | 20 | $235 |
| Levothyroxine Sodium Generic | 53 | 117 | 17 | $403 |
| Potassium Chloride Generic | 52 | 73 | 27 | $340 |
Brand drugs: - claims; generic drugs: 1,886 claims; opioid claims: 149.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anant Sharma $6,359 ($6,359 in general payments such as food, travel and fees) from 45 companies. The largest payer was Geron Corporation with $2,950.
| Company | Payments | Amount |
|---|---|---|
| Geron Corporation GERN | 9 | $2,950 |
| Novartis Pharmaceuticals Corporation NVS | 14 | $759 |
| Incyte Corporation INCY | 10 | $291 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $207 |
| Genmab U.S., Inc. GMAB | 3 | $180 |
| Pfizer Inc. PFE | 9 | $146 |
| Merck Sharp & Dohme LLC MRK | 5 | $105 |
| Astellas Pharma US Inc 4503.T | 1 | $99.95 |
| Celgene Corporation BMY | 4 | $87.08 |
| EMD Serono, Inc. MRK.DE | 3 | $79.08 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.